{
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0851-0859_Editorial.pdf": {
        "title": "Real-World Applications and Experiences of AI/ML Deployment for Drug Discovery",
        "keywords": [
            "Artificial Intelligence",
            "AI",
            "Machine Learning",
            "ML",
            "Drug Discovery",
            "Computer Science",
            "Big Data",
            "Virtual Assistants",
            "Image Generation",
            "Autonomous Vehicles",
            "Protein Structure Prediction",
            "Novel Treatments",
            "Pharmaceutical Firms",
            "Biotechs",
            "Contract Research Organizations",
            "CROs",
            "Drug Pipelines",
            "AI-enabled Companies",
            "Medicinal Chemistry",
            "Deep Learning",
            "Target Identification",
            "Hit Finding",
            "Lead Optimization",
            "Virtual Screening",
            "VS",
            "Ultralarge Chemical Databases",
            "ML Models",
            "Potency Prediction",
            "Generative Design Algorithms",
            "Molecular Structures",
            "Drug Development Partnerships",
            "Experimental Data",
            "Biological Systems",
            "Chemical Descriptors",
            "Chemical Interactions",
            "Cultural Challenges",
            "Decision-Making Biases",
            "Working Practices",
            "AI/ML Technologies Effectiveness",
            "In Silico Approaches",
            "Human Experience",
            "In-House Capabilities",
            "Talent Development",
            "Therapeutic Modalities",
            "Therapeutic Antibody Design",
            "Small Molecule Targeted Degrader Design",
            "Hit Identification",
            "Late Lead Optimization",
            "Chemical Space Representation",
            "Chemical Informatics",
            "Compound Vectors",
            "Deep Neural Networks",
            "Latent Space",
            "Molecular Fingerprints",
            "Compound Identification",
            "Vector Interpolation",
            "Patentable Chemical Space",
            "Continuous and Data-Driven Descriptors",
            "CDDD",
            "SMILES",
            "Polar Surface Area",
            "Lipophilicity",
            "Transfer Learning",
            "TL",
            "Project-Specific Training Data",
            "Molecular Similarity",
            "AE-based Seq2Seq Models",
            "Recurrent Neural Networks",
            "RNNs",
            "Transformer Architectures",
            "Data Sets",
            "Molecular Weight",
            "Latent Features",
            "Quantitative Structure-Activity Relationship",
            "QSAR",
            "Deep Generative Chemistry",
            "DGC",
            "Bayesian Optimization",
            "BO",
            "Particle Swarm Optimization",
            "PSO",
            "Inverse QSAR",
            "DGC SMILES Validity",
            "Novelty",
            "Drug-Likeness",
            "Latent Space Objective Functions",
            "Activity Prediction",
            "Absorption",
            "Distribution",
            "Metabolism",
            "Excretion",
            "Toxicity",
            "ADMET",
            "Physicochemical Properties",
            "Quantitative Structure-Property Relationship",
            "QSPR",
            "LogD",
            "Aqueous Solubility",
            "Caco2 Permeability",
            "Microsomal Clearance",
            "hERG Channel Inhibition",
            "Regression Tasks",
            "Classification Tasks",
            "Automated ML Workflow",
            "Descriptors Calculation",
            "Model Selection",
            "Hyperparameter Optimization",
            "Model Delivery",
            "Explainability Techniques",
            "Graph Neural Networks",
            "GNN",
            "Random Forest",
            "RF",
            "Compound Idea Selection",
            "Scoring Functions",
            "Targeted Properties",
            "De Novo Design Methods",
            "REINVENT",
            "Reinforcement Learning Method",
            "Pharmacophore-Based Matches",
            "Docking Scores",
            "Physicochemical Properties Models",
            "Computational Chemistry Tools",
            "Protein Modeling",
            "X-ray Crystallography",
            "Cryogenic Electron Microscopy",
            "Cryo-EM",
            "AlphaFold 2",
            "AF2",
            "Homology Models",
            "ProteinMPNN",
            "AF Multimer",
            "FoldDock",
            "AlphaFoldDB",
            "Target Ligandability Estimation",
            "RoseTTAFold-AllAtom",
            "Umol",
            "AF3",
            "Active Learning",
            "Acquisition Function",
            "Exploitation",
            "Exploration",
            "Multiparameter Optimization",
            "MPO",
            "Enamine REAL",
            "MolPal",
            "Design-Make-Test-Analyze",
            "DMTA",
            "Synthetic Tractability",
            "Retrosynthesis Prediction",
            "AI Computer-Aided Synthesis Planning",
            "CASP",
            "Electronic Laboratory Notebooks",
            "ELNs",
            "Building Block Inventories",
            "AI Retrosynthesis",
            "Synthetic Complexity Scores",
            "Safety Assessment",
            "Drug-Induced Liver Injury",
            "DILI",
            "Bile Salt Export Pump",
            "BSEP",
            "Omics Technologies",
            "High-Throughput Omics Technologies",
            "Transcriptomics Platform",
            "ScreenSeq",
            "Computational Pipelines",
            "Physics-Based Scores",
            "Orchestration",
            "BRADSHAW",
            "Knime",
            "High-Performance Computing",
            "HPC",
            "Molecular Architects",
            "MAs",
            "In Silico R&D",
            "isRD",
            "Design-Decide-Make-Test-Learn",
            "D2MTL",
            "AZ",
            "Bayer",
            "Google DeepMind",
            "MIT",
            "Animal Testing",
            "Activity Cliffs",
            "Nonadditivity",
            "Sparse Training Data",
            "LLM-based virtual assistants"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0860-0885.pdf": {
        "title": "In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects",
        "keywords": [
            "Aldo-Keto Reductase 1B10",
            "AKR1B10",
            "AKR1B10 inhibitors",
            "Cancer",
            "Chemoresistance",
            "Medicinal chemistry",
            "NADPH-dependent reduction",
            "Carbonyl compounds",
            "Gastrointestinal tract",
            "Reactive carbonyl compounds",
            "Xenobiotics",
            "Cancers",
            "Precancerous conditions",
            "Carcinogenesis",
            "Tumor development",
            "Anticancer drugs",
            "Skin pathologies",
            "COVID-19 complications",
            "Medicinal chemistry perspective",
            "Structure-activity relationships",
            "Structural studies",
            "Design strategies",
            "NAD(P)H-dependent oxidoreductases",
            "AKRs",
            "AKR superfamily",
            "AKR1-AKR16",
            "AKR1B1",
            "Aldose reductase",
            "AKR1B15",
            "Therapeutic agents",
            "Glucose metabolism",
            "Polyol pathway",
            "Hyperglycaemic conditions",
            "Diabetes mellitus",
            "DM",
            "Oxidative stress",
            "Inflammatory stress",
            "Diabetic complications",
            "Neuropathy",
            "Nephropathy",
            "Retinopathy",
            "ARIs",
            "Drug target",
            "Tumor chemoresistance",
            "Solid cancers",
            "Hepatocellular carcinoma",
            "Lung carcinoma",
            "Pancreatic carcinoma",
            "Breast carcinoma",
            "Biomarker",
            "Prognostic indicator",
            "Therapeutic response",
            "Anthracyclines",
            "Platinum complexes",
            "Cyclophosphamide",
            "Mitomycin-c",
            "Non-neoplastic pathologies",
            "Skin diseases",
            "Infectious diseases",
            "Monomeric protein",
            "Amino acids",
            "(\u03b1/\u03b2)8-barrel fold",
            "Active site",
            "Catalytic channel",
            "Amino acid residues",
            "NADP+",
            "Polar anion-binding site",
            "Hydrophobic subpocket",
            "Specificity pocket",
            "a,\u1e9e-unsaturated carbonyl compounds",
            "4-hydroxy-2-nonenal",
            "4-HNE",
            "4-oxo-2-nonenal",
            "Farnesal",
            "Geranylgeranial",
            "Subcellular localization",
            "Tissue distribution",
            "GI tract",
            "Synthetic sources",
            "Natural sources",
            "Retinoid homeostasis",
            "Retinal",
            "Retinol",
            "Alcohol dehydrogenases",
            "ADHs",
            "Aldehyde dehydrogenases",
            "ALDHs",
            "Retinoic acid",
            "Cell differentiation",
            "Cell proliferation",
            "Isoprenoid metabolism",
            "Prenylation",
            "RAS proteins",
            "MAPK signals",
            "Lipid synthesis",
            "Fatty acid synthase",
            "Acetyl-CoA carboxylase-a",
            "ACCA",
            "Phospholipids",
            "Proteasome-mediated degradation",
            "siRNAs",
            "Reactive oxygen species",
            "ROS",
            "Keap1/Nrf2 signaling pathway",
            "NF-E2-related factor",
            "Nrf2",
            "Kelch-like ECH-associated protein-1",
            "Keap1",
            "Epidermal growth factor",
            "EGF",
            "AP-1 protein",
            "Hepatocellular carcinoma",
            "HCC",
            "Nonsmall cell lung carcinoma",
            "NSCLC",
            "Matrix metalloproteinase",
            "MMP",
            "Blood-brain barrier",
            "BBB",
            "Extracellular signal-regulated kinase",
            "ERK pathway",
            "Tyrosine kinase inhibitors",
            "TKIs"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0886-0901.pdf": {
        "title": "Targeting IspD for Anti-infective and Herbicide Development: Exploring Its Role, Mechanism, and Structural Insights",
        "keywords": [
            "IspD",
            "Anti-infectives",
            "Herbicides",
            "MEP pathway",
            "Methyl-D-erythritol phosphate pathway",
            "Antimicrobial resistance",
            "AMR",
            "Drug discovery",
            "Enzyme inhibition",
            "Structural insights",
            "Catalytic mechanism",
            "Pseudomonas aeruginosa",
            "Mycobacterium tuberculosis",
            "Plasmodium falciparum",
            "2-C-methylerythritol-D-erythritol-4-phosphate",
            "IDP",
            "Isopentenyl diphosphate",
            "DMADP",
            "Dimethylallyl diphosphate",
            "DoGSiteScorer",
            "Allosteric pocket",
            "Arabidopsis thaliana",
            "AtIspD",
            "4-diphosphocytidyl-2C-methyl-D-erythritol synthase",
            "ygbp gene",
            "CTP",
            "CDP-ME",
            "4-diphosphocytidyl-2C-methyl-D-erythritol",
            "Mt",
            "Gram-negative bacteria",
            "Pa",
            "Human cells",
            "Off-target effects",
            "Druggability",
            "Active site",
            "Hydrophilic",
            "Hydrophobic character",
            "Nanomolar activity",
            "Enzyme kinetics",
            "Substrate binding",
            "Cofactor binding",
            "Enzyme structure",
            "Homodimer",
            "Rossmann-like fold",
            "Beta-arm",
            "Active site residues",
            "Allosteric inhibitors",
            "Human IspD",
            "HsIspD",
            "Dystroglycan O-mannosylation",
            "Walker-Warburg syndrome",
            "Enzymatic assay",
            "Rescue assay",
            "Substrate modification",
            "Molecular docking",
            "Competitive inhibitors",
            "BITZ",
            "2-phenyl benzo[d]isothiazol-3(2H)-one",
            "Covalent mechanism",
            "Cys-202",
            "Disulfide bond",
            "MMV-08138",
            "Phenotypic screening",
            "IDP rescue",
            "Enantiomeric separation",
            "1R,3S conformer",
            "SAR studies",
            "MEPN3",
            "Azolopyridines",
            "Pseudilines",
            "Halogen bonding",
            "Pyrrolopyrazines",
            "Urea class",
            "Biphenyl carboxylic acid",
            "Aminobenzothiazoles",
            "Desmethylated MEP",
            "Fluoroalkyl phosphonyl analogues",
            "LC-MS",
            "Metabolic stress",
            "WHO report",
            "Bacterial priority pathogens",
            "Broad-spectrum anti-infectives",
            "Crystal structure",
            "PDB accession code",
            "1INI",
            "1152",
            "1W77",
            "2XWN",
            "2XWM",
            "5DDT",
            "5HS2",
            "2YC3",
            "2YC5",
            "2YMC",
            "4NAL",
            "4NAN",
            "5MRM",
            "Non-competitive inhibition",
            "Enzyme-substrate complex",
            "Drug targets",
            "In silico analysis",
            "Structure-activity relationship",
            "Protein engineering",
            "Enzyme engineering",
            "Drug resistance",
            "Herbicide resistance",
            "Metabolic profiling",
            "Enzyme selectivity",
            "Protein-ligand interactions",
            "Enzyme regulation",
            "Protein dynamics",
            "Enzyme evolution",
            "Enzyme design",
            "Rational drug design"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0902-0914.pdf": {
        "title": "Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects",
        "keywords": [
            "Interleukin-1 Receptor-Associated Kinase 4",
            "IRAK4",
            "IRAK4 degraders",
            "Inflammatory diseases",
            "Kinase function",
            "Scaffolding function",
            "Myddosome assembly",
            "NF-kB activation",
            "KT-474",
            "SAR444656",
            "Inflammatory biomarker",
            "Tolerability",
            "Physiological biology",
            "Associated diseases",
            "Future research directions",
            "Therapeutic target",
            "Conventional IRAK4 inhibitors",
            "Limited efficacy",
            "Innovative candidate drugs",
            "Autoimmune diseases",
            "Heterobifunctional degrader",
            "Clinical activity",
            "Immune system",
            "Invading virus",
            "Bacteria",
            "Pleiotropic process",
            "Innate immunity",
            "Specific immunity",
            "Metabolism",
            "Cell integrity",
            "Organelle integrity",
            "Inflammatory mediator release",
            "White blood cell infiltration",
            "Tissue repair",
            "Regeneration",
            "Cytokine storm",
            "Multiple organ dysfunction syndrome",
            "Tissue cell death",
            "Severe damage",
            "Signal nodes",
            "Inflammatory response signaling pathway",
            "Drug development",
            "Toll-like receptors",
            "TLRs",
            "Damage-associated molecular patterns",
            "Pathogen-associated molecular patterns",
            "Interleukin-1 receptor",
            "IL-1R",
            "Myeloid differentiation primary response 88",
            "MyD88",
            "Death domain",
            "DD",
            "IRAK family",
            "IRAK1",
            "IRAK2",
            "IRAK3",
            "Autoimmune disorders",
            "PF-06650833",
            "BAY-1830839",
            "Zabedosertib",
            "BAY1834845",
            "Edecesertib",
            "Emavusertib",
            "CA-4948",
            "Dual roles",
            "Small-molecule inhibitors",
            "Clinical efficacy",
            "Rheumatoid arthritis",
            "RA",
            "Hidradenitis suppurativa",
            "HS",
            "Placebo",
            "Atopic dermatitis",
            "AD",
            "Proteolysis-targeting chimeras",
            "PROTACs",
            "Ubiquitylation",
            "Protein of interest",
            "POI",
            "Ubiquitin-proteasome system",
            "Nonenzymatic functions",
            "Focal adhesion kinase",
            "FAK",
            "Discoidin domain receptor 1",
            "Aurora",
            "Cytokine production",
            "Phase 1 clinical trials",
            "Pattern-recognition receptors",
            "PRRs",
            "TLR4",
            "Immune cells",
            "Macrophages",
            "Dendritic cells",
            "Epithelial cells",
            "Fibroblast cells",
            "Bacterial components",
            "Fungal components",
            "Viruses",
            "Microbial nucleic acids",
            "Endogenous stimulatory molecules",
            "TIR domains",
            "Signalosome",
            "Transautophosphorylation",
            "Interferon response regulatory factor",
            "IRF",
            "TNF receptor-associated factor 6",
            "TRAF6",
            "Lys63",
            "K63",
            "Transforming growth factor-activated kinase-1",
            "TAK1",
            "IKB kinase",
            "IKK",
            "AP-1",
            "Target gene expression",
            "Autophosphorylation",
            "Ubiquitylation",
            "Ubiquitin",
            "Ub",
            "El enzymes",
            "E2 Ub-conjugating enzyme",
            "E3 Ub ligase",
            "PolyUb chain",
            "26S proteasomal degradation pathway",
            "Post-translational IRAK4 modifications"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0915-0928.pdf": {
        "title": "UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?",
        "keywords": [
            "UBE2N",
            "Ubiquitin-conjugating enzyme E2 N",
            "cancer",
            "anticancer therapies",
            "UBE2N inhibitors",
            "UBE2Ni",
            "DNA repair",
            "covalent inhibitors",
            "noncovalent inhibitors",
            "druggability",
            "pharmacokinetic properties",
            "UE2s family",
            "ubiquitin",
            "E1 enzyme",
            "E3 ligases",
            "Ub transfer pathway",
            "ubiquitination processes",
            "neddylation",
            "SUMOylation",
            "ISGylation",
            "cysteine residue",
            "3D structures",
            "protein-protein interactions",
            "therapeutic targets",
            "cancer treatment",
            "in vivo models",
            "modes of inhibition",
            "Ubc13",
            "cancer processes",
            "chemoinformatic work",
            "interaction surfaces",
            "K48-linked poly-Ub chain",
            "K63 ubiquitination",
            "NF-kB signaling",
            "\u03b2-amyloid plates accumulation",
            "UBE2 V2",
            "Mms2",
            "histone H2A",
            "DNA double-strand breaks",
            "RAP80",
            "BRCA1",
            "UBE2 V1",
            "Uevla",
            "TRAF6 E3 ligase",
            "IKK",
            "IkB kinase",
            "PD-L1",
            "Programmed Death-Ligand 1",
            "ovarian cancer",
            "AML",
            "Acute Myeloid Leukemia",
            "monotherapy",
            "DNA damaging therapies",
            "radiotherapy",
            "platinum agents",
            "PARP inhibitors",
            "PARPi",
            "breast cancer cells",
            "carboplatin",
            "tumor organoids",
            "neo-antigen presentation",
            "antitumoral immunity",
            "NK-kB",
            "\u03b2-amyloid accumulation",
            "Alzheimer disease",
            "E2 cofactors",
            "ZNRF1",
            "LNX1",
            "RNF4",
            "RNF8",
            "TRIMs",
            "STIP1",
            "Stitch",
            "OTUB1",
            "BAY 11-7082",
            "NSC697923",
            "UC-764864",
            "UC-764865",
            "Michael acceptors",
            "nitrofuran moiety",
            "para-methylphenylsulfone moiety",
            "MOLM-13",
            "human leukemia",
            "MALDI TOF-MS",
            "leucettamol A",
            "manadosterols",
            "variabines",
            "peptoids",
            "SPR assays",
            "PC-3 prostate cancer cells",
            "ML307",
            "TR-FRET",
            "ADME properties",
            "covalent-warhead",
            "Computer-aided drug design",
            "Gold",
            "DOCKovalent",
            "CovDock",
            "molecular dynamics simulations",
            "protein-protein interaction disruptor",
            "therapeutic modalities"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0929-0943.pdf": {
        "title": "Targeting QPCTL: An Emerging Therapeutic Opportunity",
        "keywords": [
            "QPCTL",
            "Glutaminyl-peptide cyclotransferase-like protein",
            "glutaminyl cyclase",
            "glutaminyl-peptide cyclo-transferase",
            "N-terminal glutamine",
            "glutamate",
            "pyroglutamate",
            "pGlu",
            "CD47",
            "signal-regulatory protein alpha",
            "SIRPa",
            "tumor cells",
            "immune cells",
            "CCL2",
            "C-C motif chemokine ligand 2",
            "MCP-1",
            "monocyte chemoattractant protein-1",
            "CCL7",
            "C-C motif chemokine ligand 7",
            "MCP-3",
            "CX3CL1",
            "tumor microenvironment",
            "inflammatory responses",
            "therapeutic target",
            "human diseases",
            "small-molecule inhibitors",
            "structural features",
            "catalytic mechanisms",
            "biological functions",
            "novel QPCTL inhibitors",
            "cancer",
            "inflammatory diseases",
            "research directions",
            "challenges",
            "QPCTL inhibitors",
            "glutaminyl cyclases",
            "protein maturation",
            "posttranslational modification",
            "isoenzymes",
            "QC",
            "sQC",
            "isoQC",
            "gQC",
            "Carica papaya",
            "eukaryotes",
            "prokaryotes",
            "glands",
            "neuronal tissue",
            "Golgi apparatus",
            "N-terminal signal anchor",
            "Alzheimer's disease",
            "AD",
            "Huntington's disease",
            "HD",
            "integrin-associated protein",
            "cluster of differentiation 47",
            "CD172a",
            "myeloid cells",
            "don't eat me signal",
            "tumor immune evasion",
            "macrophage-mediated phagocytosis",
            "tumor immunity",
            "leukocytes",
            "tumor immunotherapy",
            "cytoplasmic region",
            "transmembrane region",
            "Golgi-luminal region",
            "X-ray crystal structure",
            "active site pocket",
            "hydrophobic substrates",
            "amino acid sequence",
            "catalytic hydrogen bond network",
            "substrate binding site",
            "electrostatic environments",
            "subtype-selective inhibitors",
            "zinc-dependent catalytic machanism",
            "synchronized proton transfer",
            "His330",
            "Glu202",
            "Asp159",
            "Glu201",
            "Asp305",
            "Asp248",
            "Gln-Pro motif",
            "dipeptidyl peptidase 4",
            "DPP4",
            "\u1e9e-amyloid",
            "A\u00df",
            "microglia",
            "aminopeptidases",
            "gene knockout studies",
            "monocyte infiltration",
            "chemokine",
            "eosinophils",
            "T cells",
            "monocyte homeostasis",
            "N-terminus",
            "C-X3-C motif chemokine ligand 1",
            "CX3CL1",
            "CX3CR1",
            "fractalkine receptor 1",
            "integrin-independent adhesion",
            "BTN2A1",
            "BTN3A1",
            "BTN3A2",
            "BTN3A3",
            "Vr9 V82 T cell",
            "collagen",
            "fibronectin",
            "uncontrolled cell division",
            "neuro-degeneration",
            "overexpression",
            "cutaneous melanoma",
            "brain glioma",
            "sarcoma",
            "renal carcinoma",
            "colon cancer",
            "esophageal cancer",
            "cholangiocellular carcinoma",
            "transmembrane protein",
            "integrins",
            "thrombospondin-1",
            "TSP-1",
            "SH2-domain-containing protein tyrosine phosphatase substrate-1",
            "SHPS-1",
            "normal epithelial cells",
            "platelets",
            "immunoreceptor tyrosine-based inhibitory motifs",
            "ITIMs",
            "Src family kinases"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0944-0952.pdf": {
        "title": "Insights for the Next Generation of Ketamine for the Treatment of Depressive Disorder",
        "keywords": [
            "Ketamine",
            "Depression",
            "Antidepressant",
            "N-methyl-D-aspartate receptor",
            "NMDAR",
            "Prefrontal cortex",
            "PFC",
            "(R)-enantiomer",
            "(S)-enantiomer",
            "(2R,6R)-Hydroxynorketamine",
            "HNK",
            "mGlu2",
            "Brain-derived neurotrophic factor",
            "BDNF",
            "Tropomyosin receptor kinase B",
            "TrkB",
            "Synaptogenesis",
            "Pharmacology",
            "Metabolism",
            "Animal studies",
            "Human studies",
            "Enantiomers",
            "Major depressive disorder",
            "MDD",
            "Monoaminergic-based medication",
            "Rapid-acting antidepressant",
            "N-methyl-D-aspartate receptor antagonist",
            "Neuroplasticity",
            "MU opioid receptors",
            "MORs",
            "Kappa opioid receptors",
            "Preclinical model",
            "Blood-brain barrier",
            "Antidepressant-like effect",
            "Sex differences",
            "Pharmaceutical-based therapies",
            "Efficacious treatment option",
            "Selective serotonin/norepinephrine reuptake drugs",
            "Dissociative anesthetic",
            "Anxiety",
            "Post-traumatic stress disorder",
            "PTSD",
            "Glutamatergic transmission",
            "Synaptic plasticity",
            "Meta-analysis",
            "Randomized control trials",
            "RCTs",
            "Suicidal ideation",
            "Serotonin selective reuptake inhibitors",
            "SSRIs",
            "Treatment-resistant depression",
            "TRD",
            "Intravenous ketamine-HCl infusion",
            "Depressive symptoms",
            "Rodent models",
            "Norketamine",
            "Pharmacodynamic properties",
            "Chronic neuropathic pain",
            "Pharmacokinetics",
            "(2S,6S and 2R,6R)-hydroxynorketamine",
            "Learned helplessness model",
            "Hepatic metabolism",
            "Tolerance to ketamine",
            "Urinary components",
            "Bladder inflammation",
            "Fibrosis",
            "Depressive-like behavior",
            "Unpredictable chronic stress exposure",
            "Genetic manipulation",
            "Learned helplessness model",
            "Social defeat model",
            "Olfactory bulbectomy model",
            "Neuroinflammation",
            "Synaptic dysfunction",
            "Cognition",
            "Emotion",
            "Anhedonia",
            "Despair",
            "Hopelessness",
            "Locomotor activity",
            "Early life stress",
            "Glucocorticoid models",
            "Corticosterone models",
            "Chronic restraint stress models",
            "Horses",
            "Zebrafish",
            "Nonhuman primates",
            "Rats",
            "CUMS",
            "Behavioral despair",
            "BD",
            "Learned helplessness",
            "LH",
            "Chronic social defeat stress",
            "CSDS",
            "Drug withdrawal",
            "Transgenic animal models",
            "Chronic Unpredictable Mild Stress-Induced Depression",
            "Biomarkers",
            "Proteomic markers",
            "Cytokines",
            "Inflammatory markers",
            "Metabolic markers",
            "Oxidative stress markers",
            "Endocrine markers",
            "Structural and functional magnetic resonance imaging",
            "MRI",
            "Cerebral cortical thickness",
            "Emotional conflict tests",
            "Interleukin-6",
            "IL-6",
            "C-reactive protein",
            "CRP",
            "Interleukin-8",
            "IL-8",
            "Chemokine monocyte chemoattractant protein-1",
            "TNF-a",
            "Leptin",
            "Ghrelin",
            "Adiponectin",
            "Lipid profile",
            "Malondialdehyde",
            "Superoxide dismutase",
            "SOD",
            "Neurotransmitters",
            "Deep brain stimulation",
            "DBS",
            "Interleukins",
            "Macrophage inhibitory protein 1a",
            "Granulocyte-macrophage colony-stimulating factor",
            "Interferon gamma-induced protein 10",
            "Chemokine thymus",
            "Activation of regulated chemokines",
            "Tyrosine kinase 2 growth factor"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0953-0985.pdf": {
        "title": "G9a/GLP Modulators: Inhibitors to Degraders",
        "keywords": [
            "G9a",
            "GLP",
            "G9a/GLP",
            "Histone methylation",
            "Epigenetics",
            "Histone methyltransferase",
            "HMT",
            "H3K9",
            "Histone H3 lysine 9",
            "H3K27",
            "DNA",
            "Deoxyribonucleic acid",
            "Gene expression",
            "Cancer",
            "Anticancer therapy",
            "Alzheimer's disease",
            "AD",
            "G9a inhibitors",
            "G9a degraders",
            "Signaling pathways",
            "Therapeutic potential",
            "G9a-like protein",
            "Euchromatic histone lysine methyltransferase 2",
            "Euchromatic histone lysine methyltransferase 1",
            "HKMTs",
            "Histone lysine methyl transferases",
            "SAM",
            "S-adenosyl-L-methionine",
            "Chromatin",
            "H1",
            "Peripheral blood leukocytes",
            "Bone marrow",
            "Skeletal muscle",
            "Corepressors",
            "Genomic imprinting",
            "Embryonic development",
            "Apoptosis",
            "Embryonic stem cells",
            "H3K9me2",
            "H3K9 dimethylation",
            "Chromatin domain condensation",
            "SET domain",
            "Su(var.)",
            "E(z)",
            "Trithorax",
            "SUV39H1",
            "SUV39H2",
            "Ankyrin repeat domain",
            "H3K9me1/2",
            "H3K9me3",
            "Nonhistone proteins",
            "Cellular processes",
            "DNMT1",
            "DNA methyltransferase 1",
            "Heterochromatic regions",
            "Hepatocellular carcinoma",
            "Brain cancer",
            "Esophageal squamous cell carcinoma",
            "Ovarian carcinoma",
            "Multiple myeloma",
            "Tumor suppressors",
            "E-Cadherin",
            "CDH1",
            "Tumor protein p53",
            "Oncogenic signaling pathways",
            "Hypoxia response",
            "TGF-\u03b2",
            "Transforming growth factor",
            "Epithelial-to-mesenchymal transition",
            "Fibrosis",
            "Foot-and-mouth disease",
            "Prader-Willi syndrome",
            "Sarcomere assembly issues",
            "Pain",
            "Globin disorders",
            "Sickle cell disease",
            "SCD",
            "Fetal y-globin",
            "Adult \u03b2-globin genes",
            "Neurodegeneration",
            "Cognitive impairment",
            "Medicinal chemists",
            "Small-molecule inhibitors",
            "Substrate-pocket binding inhibitors",
            "Quinazoline-based inhibitors",
            "High throughput screening",
            "HTS",
            "BIX-01294",
            "PRMT1",
            "Protein arginine methyltransferase 1",
            "AdoHcy",
            "S-adenosyl-L-homocysteine",
            "UNC0224",
            "UNC0321",
            "E72",
            "MS012",
            "RK-701",
            "HKMTI-1-247",
            "HKMTI-1-248",
            "CPUY074001",
            "CPUY074020",
            "DCG066",
            "Raltitrexed",
            "CM-272",
            "W4032",
            "BIX-01338",
            "BRD4770",
            "BRD9539",
            "Chaetocin",
            "Sinefungin",
            "EML741",
            "MS8511",
            "Cys1098",
            "Cys1186",
            "PROTACs",
            "Proteolysis targeting chimeras",
            "MS8709",
            "G9D-4",
            "W4032",
            "TM2-115",
            "Pf3D7"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/0986-1001.pdf": {
        "title": "Fragment-to-Lead Medicinal Chemistry Publications in 2023",
        "keywords": [
            "Fragment-to-Lead",
            "F2L",
            "Medicinal Chemistry",
            "Publications",
            "2023",
            "Fragment-based drug discovery",
            "FBDD",
            "Drug Discovery",
            "Fragment Screening",
            "Lead Optimization",
            "NMR",
            "Virtual Screening",
            "Fragment Library Design",
            "Fragment Linking",
            "Hit Finding",
            "Lead Compound",
            "Molecular Weight",
            "MW",
            "Potency",
            "Affinity",
            "Target Classes",
            "Kinases",
            "Proteases",
            "Enzymes",
            "GPCR",
            "G Protein-Coupled Receptors",
            "SciFinder",
            "Journal of Medicinal Chemistry",
            "ACS Medicinal Chemistry Letters",
            "Bioorganic & Medicinal Chemistry",
            "Practical Fragments blog",
            "Bioassay",
            "Biophysical Method",
            "X-ray",
            "Virtual Screen",
            "cLogP",
            "Ligand Efficiency",
            "LE",
            "Ligand-Lipophilicity Efficiency",
            "LLE",
            "Astex Ligand Lipophilicity Efficiency",
            "LLEAT",
            "PDB Code",
            "Structure-Based Drug Design",
            "SBDD",
            "Molecular Dynamics",
            "MD",
            "SPR",
            "Surface Plasmon Resonance",
            "Mass Spectrometry",
            "Covalent Inhibitors",
            "Disulfide Tethering",
            "Protein-Protein Interactions",
            "PPI",
            "Electrophilic Fragments",
            "Library Design",
            "H-bond donor",
            "HBD",
            "PROTACs",
            "Proteolysis Targeting Chimeras",
            "Protein Database",
            "PDB",
            "FRAGTORY",
            "KNIME",
            "Sustainability",
            "Renewable Resources",
            "Biomass",
            "Cyrene",
            "Halo Library",
            "Halogen Atoms",
            "Fragment vs Lead Properties",
            "Deviation From Planarity",
            "DFP",
            "Fragment Growth",
            "Fragment Merging",
            "Entropy Gains",
            "Fragmenstein",
            "Chemical Synthesis",
            "Self-Assembly",
            "Computational Techniques",
            "Density Functional Theory",
            "DFT",
            "Fragments on Energy Surfaces",
            "FOES",
            "Genetic Algorithm",
            "Pharmocophore Mapping",
            "DeepFMPO",
            "Virtual Fragment Libraries",
            "Poised DEL",
            "DNA-Encoded Chemical Library",
            "NUDEL",
            "MiniFrags",
            "FragLites",
            "Microscale High-Throughput Optimization",
            "Suzuki-Miyaura Couplings",
            "Buchwald-Hartwig Couplings",
            "Nucleophilic Aromatic Substitutions",
            "C-H Functionalization",
            "Transformational Chemistry",
            "AI",
            "Artificial Intelligence",
            "DCAF1",
            "DDB1 and CUL4-Associated Factor 1",
            "EGFR",
            "Epidermal Growth Factor Receptor Kinase",
            "NOX2",
            "Nicotinamide Adenine Dinucleotide Phosphate Oxidase Isoform 2",
            "SARS-CoV-2",
            "Severe Acute Respiratory Syndrome Coronavirus 2",
            "VE-PTP",
            "Vascular Endothelial Protein Tyrosine Phosphatase"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1002-1020.pdf": {
        "title": "Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy",
        "keywords": [
            "KAT6A",
            "KAT6B",
            "Lysine acetyltransferase 6A",
            "Lysine acetyltransferase 6B",
            "MYST family",
            "Protein acetyltransferases",
            "Craniofacial development",
            "Embryonic development",
            "Stem cell development",
            "Hematopoiesis",
            "Oncogene",
            "Acute myeloid leukemia",
            "AML",
            "Metastases",
            "Poor prognoses",
            "Cancer formation",
            "Cancer progression",
            "Therapeutic resistance",
            "Hematopoietic malignancies",
            "Solid tumors",
            "Anticancer activities",
            "Anticancer drug candidates",
            "Cancer therapy",
            "Public health challenge",
            "Mortality",
            "Chemotherapy",
            "Targeted therapy",
            "Immunotherapy",
            "Cell/gene therapy",
            "Toxic side effects",
            "Drug resistances",
            "Treatment strategies",
            "Genetic alterations",
            "Epigenetic alterations",
            "Tumorigenesis",
            "Tumor suppressor genes",
            "Oncogenes",
            "Protein post-transcriptional modifications",
            "PTMs",
            "Acetylation",
            "Phosphorylation",
            "Ubiquitination",
            "Histone lysine residues",
            "Histone PTMs",
            "Cellular signaling network",
            "Histone acetyltransferases",
            "HATs",
            "Histone deacetylases",
            "HDACs",
            "Chromatin structure",
            "Gene expression",
            "Drug development",
            "Epigenetic regulations",
            "Histone acetylation",
            "Belinostat",
            "Panobinostat",
            "Cutaneous T-cell lymphoma",
            "Multiple myeloma",
            "GS-5829",
            "OTX015",
            "Bromodomain-containing protein 4",
            "BRD4",
            "Brain tumors",
            "Hematological malignancies",
            "Leukemia",
            "Breast cancer",
            "Hepatocellular carcinoma",
            "HCC",
            "Nonhistone proteins",
            "p53",
            "Tetrameric complex",
            "Inhibitor of growth 5",
            "ING5",
            "Esa1-associated factor 6 ortholog",
            "EAF6",
            "Bromodomain-PHD finger protein",
            "BRPF1",
            "Histone H3 tails",
            "Proto-oncogenes",
            "Tumor suppressor genes",
            "Transcription factors",
            "RUNX1",
            "P21 expression",
            "Cellular senescence",
            "KAT6A fusion proteins",
            "Molecular structure",
            "MYST family members",
            "HAT",
            "KAT5",
            "TIP60",
            "KAT7",
            "HOB1",
            "KAT8",
            "MOF",
            "MYST domain",
            "Acetyl-CoA-binding motif",
            "PHD-type zinc finger domain",
            "Chromosomal translocation",
            "Transcription intermediary factor 2",
            "TIF2",
            "CAMP response element-binding protein",
            "CBP",
            "KAT6A-TIF2 fusion protein",
            "Hematopoietic progenitors",
            "Functional domains",
            "Double plant homologous",
            "Glutamate/aspartate-rich region",
            "Acidic",
            "Serine/methionine-rich region",
            "SM",
            "N-terminal region",
            "NEMM region"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1021-1032.pdf": {
        "title": "Positioning Enzyme- and Transporter-Based Precipitant Drug-Drug Interaction Studies in Drug Design",
        "keywords": [
            "Drug-Drug Interactions",
            "DDIs",
            "Enzyme Inhibition",
            "Transporter Inhibition",
            "Drug Design",
            "Medicinal Chemistry",
            "Pharmacokinetics",
            "In Vitro Assessment",
            "Regulatory Agencies",
            "Clinical Studies",
            "Drug Metabolizing Enzymes",
            "Transporters",
            "Cytochrome P450",
            "CYP",
            "CYP3A4",
            "CYP2C9",
            "CYP2D6",
            "Organic Anion Transporting Polypeptide",
            "OATP",
            "OATP1B1",
            "Breast Cancer Resistant Protein",
            "BCRP",
            "High-Throughput Screening",
            "Drug Disposition",
            "Medical Need",
            "Comedications",
            "Precipitant Drug",
            "Object Drug",
            "Reversible Inhibition",
            "Irreversible Inactivation",
            "Time-Dependent Inhibition",
            "TDI",
            "Enzyme Induction",
            "mRNA",
            "Gene Transcription",
            "Human Hepatocytes",
            "PXR",
            "CAR",
            "AhR",
            "Clinical Development Strategy",
            "AUCR",
            "ICH M12",
            "UGT",
            "UDP-glucuronosyltransferases",
            "Renal Drug Transporters",
            "OCT2",
            "OAT1/3",
            "MATE1/2k",
            "Intestinal Efflux Transporters",
            "P-gp",
            "P-glycoprotein",
            "MDR1",
            "Digoxin",
            "Atrial Fibrillation",
            "AF",
            "Rhabdomyolysis",
            "Bioequivalence Criteria",
            "Product Label",
            "Structure-Activity Relationships",
            "HLM",
            "Human Liver Microsomes",
            "IC50",
            "Kinact",
            "K\u2081",
            "Kobs",
            "Emax",
            "EC50",
            "R3 Equation",
            "Single-Point Assessment",
            "Transwell Assays",
            "MDCK Cells",
            "Membrane Vesicle Preparations",
            "Mechanistic Static Models",
            "Physiologically-Based Pharmacokinetic Models",
            "PBPK Models",
            "Dose Adjustment",
            "Drug Safety",
            "Pharmacogenomics",
            "Drug Clearance",
            "Drug Absorption",
            "Drug Distribution",
            "Drug Metabolism",
            "Drug Excretion",
            "Drug Toxicity",
            "Adverse Events",
            "Clinical Significance",
            "Therapeutic Index",
            "Drug Interactions Database",
            "Certara",
            "In Vitro-In Vivo Extrapolation",
            "IVIVE",
            "ADME",
            "Absorption Distribution Metabolism Excretion",
            "Small Molecule Drugs",
            "Drug Candidates",
            "Drug Discovery",
            "Drug Development",
            "Drug Research",
            "Drug Approval",
            "Drug Marketing",
            "Drug Withdrawal",
            "Drug Labeling",
            "Drug Prescription",
            "Drug Comedication",
            "Drug Polymorphism",
            "Drug Phenotype",
            "Drug Genotype"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1033-1050.pdf": {
        "title": "Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors",
        "keywords": [
            "Glucose Transporter",
            "GLUT",
            "GLUT inhibitors",
            "Cancer therapy",
            "Medicinal chemistry",
            "Class I GLUTs",
            "SGLT",
            "Sodium-coupled glucose cotransporters",
            "Warburg effect",
            "Aerobic glycolysis",
            "Tumor cells",
            "Glucose uptake",
            "Metabolic substrates",
            "ATP",
            "Glycoprotein",
            "Transmembrane a-helical arrays",
            "Isoforms of GLUT",
            "Heidelberg Unix sequence analysis",
            "Class II GLUTs",
            "Class III GLUTs",
            "GLUT1",
            "GLUT2",
            "GLUT3",
            "GLUT4",
            "GLUT14",
            "GLUT5",
            "GLUT7",
            "GLUT9",
            "GLUT11",
            "GLUT6",
            "GLUT8",
            "GLUT10",
            "GLUT12",
            "GLUT13",
            "HMIT",
            "H+/myoinositol transporter",
            "TM",
            "Transmembrane domains",
            "Glutor",
            "Anticancer therapeutics",
            "Erythrocyte-type glucose transporter",
            "Extravascular glucose",
            "Galactose",
            "Mannose",
            "Glucosamine",
            "Human T cell leukemia virus type 1",
            "CD4+ T cell activation",
            "Brain cancer",
            "Lung cancer",
            "Breast cancer",
            "Hepatocellular cancer",
            "Gastric cancer",
            "Colorectal cancer",
            "Intestinal cancer",
            "Renal cancer",
            "Bladder cancer",
            "Pancreatic cancer",
            "Thyroid cancer",
            "Laryngeal cancer",
            "Esophageal cancer",
            "Oral cancer",
            "Penile cancer",
            "Uterine cancer",
            "Endometrial cancer",
            "Cervical cancer",
            "Ovarian cancer",
            "Anticancer agents",
            "Fructose",
            "Docosahexaenoic acid",
            "DHA",
            "Insulin stimulation",
            "Prostate cancer",
            "Castration-resistant prostate cancer",
            "Squamous cell carcinoma",
            "Lymph node status",
            "Recurrence status",
            "Alzheimer's disease",
            "Gastric adenocarcinoma",
            "Dietary fructose",
            "Metabolic complications",
            "Insulin resistance",
            "Fatty liver disease",
            "Obesity",
            "Benign prostate",
            "Prostate cancer",
            "Multiple myeloma",
            "Hyperuricemia",
            "Crystal structures",
            "N-nonyl-\u03b2-D-glucopyranoside",
            "\u03b2-NG",
            "ICH",
            "Intracellular helical bundle",
            "Cytochalasin B",
            "CCB",
            "GLUT-il",
            "GLUT-i2",
            "Small-molecule inhibitors",
            "Fasentin",
            "WZB27",
            "WZB115",
            "WZB117",
            "DRB18",
            "CUM-5",
            "2,4-thiazolidinedione",
            "TZD",
            "NV-5440",
            "NV-6297",
            "Glutipyran",
            "SRI-37683",
            "SRI-37684",
            "RgA",
            "KL-11743",
            "STF-31",
            "BAY-876",
            "NSC295720",
            "SMI277",
            "MSNBA",
            "Cytochalasin B",
            "Phloretin",
            "Curcumin",
            "Apigenin",
            "Isobavachin",
            "Chromopynone-1",
            "Glupin"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1051-1067.pdf": {
        "title": "In Pursuit of Lead Innovation: Pharmaceutically Important and Distinct Amide-Free Succinate Dehydrogenase Inhibitors",
        "keywords": [
            "Succinate Dehydrogenase Inhibitors",
            "SDHIs",
            "Amide-free SDHIs",
            "Fungicide Resistance",
            "Agrochemical Industry",
            "Antifungal Structures",
            "Bioactive Compounds",
            "Synthetic Endeavors",
            "Natural Sources",
            "Biological Activities",
            "Mechanism of Action",
            "Pharmaceutical Discoveries",
            "Efficient Synthesis Methods",
            "Chemical Entities",
            "Agrochemicals",
            "Mitochondrial Respiratory Complex II",
            "Succinate-Ubiquinone Oxidoreductase",
            "SQR",
            "Electron Transport Chain",
            "Krebs Cycle",
            "SDH Subunits",
            "SDH-A",
            "SDH-B",
            "SDH-C",
            "SDH-D",
            "Ubiquinone Binding Pocket",
            "Q Site",
            "Fungicides",
            "Carboxin",
            "Basidiomycete Fungi",
            "Boscalid",
            "Ascomycete Fungi",
            "Biphenylamine",
            "Amine Building Blocks",
            "Carboxylic Acid Building Blocks",
            "21st Century Fungicides",
            "Fluopyram",
            "Pydiflumetofen",
            "Nematicidal Activity",
            "Fusarium Graminearum",
            "Cyclobutrifluram",
            "Syngenta",
            "Mode of Resistance",
            "Molecular Level",
            "Genetic Level",
            "Fungicide Resistance Action Committee",
            "SciFinder Search",
            "Complex II Inhibitor",
            "Succinate Ubiquinone Oxidoreductase Inhibitor",
            "1,3-Ketones",
            "Phenols",
            "Aromatic Acids",
            "Analogs",
            "Fluorosuccinic Acids",
            "2,2-Difluorosuccinate",
            "Monofluorofumarate",
            "Perfluorosuccinic Acids",
            "Competitive Inhibitors",
            "Monofluorosuccinate",
            "Difluorosuccinate",
            "Oxaloacetate",
            "Malonate",
            "Malate",
            "\u00df-Methoxybenzoyl-\u00df-Bromoacrylic Acid",
            "Noncompetitive Inhibitor",
            "3-Nitropropionic Acid",
            "3-NPA",
            "Irreversible Inhibitor",
            "Dopamine Uptake",
            "Mesencephalic Neurons",
            "Oxidative Phosphorylation",
            "Hydrogen Peroxide",
            "Peroxynitrite",
            "Mitochondrial Permeability Transition",
            "Caudate-Putamen",
            "Quinol-Fumarate Oxidoreductases",
            "QFRs",
            "\u03b1-Thenoyltrifluoroacetone",
            "TTFA",
            "Porcine Liver Carboxylesterase",
            "Human Umbilical Vascular Endothelial Cells",
            "HUVECs",
            "PDB Code 1ZP0",
            "Pentachlorophenol",
            "PCP",
            "Dinitrophenol-17",
            "DNP-17",
            "Dinitrophenol-19",
            "DNP-19",
            "PDB Codes 1NEN",
            "PDB Codes 2WDR",
            "PDB Codes 1KFY",
            "Structure-Activity Relationships",
            "SARs",
            "Hydroxybenzoic Acids",
            "Gallic Acid",
            "Vanillic Acid",
            "Cyflumetofen",
            "Cyenopyrafen",
            "Otsuka AgriTechno Co.",
            "\u00df-Keto Nitriles",
            "2-Cyano-5-Oxopentanoic Acid",
            "Sclerotinia Sclerotiorum",
            "PDB ID IZOY",
            "2-Phenylindole",
            "Thiazolobenzimidazoles",
            "Arylindolyl-Methyleneoxazolones",
            "Indolylvinylquinazolinones",
            "N-Aryl-N-Pyridyl Thiobarbiturates",
            "2-Heptyl-4-Hydroxyquinoline N-Oxide",
            "2-Heptyl-HQNO",
            "mKATP Opener",
            "Thiabendazole",
            "TBZ",
            "Pyrazolyl-Phenol ME1111",
            "Pyrimidine Analogs",
            "Stolonoxides",
            "Acetogenins",
            "Maesaquinone",
            "Siccanin",
            "Atpenins",
            "Harmine"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1068-1089.pdf": {
        "title": "Current and Emerging Approaches Targeting G9a for the Treatment of Various Diseases",
        "keywords": [
            "G9a",
            "Histone lysine methyltransferase",
            "Epigenetic modifications",
            "Gene expression",
            "Human diseases",
            "Cancer",
            "Small molecule inhibitors",
            "Clinical trials",
            "Preclinical efficacy",
            "DS79932728",
            "Sickle cell disease",
            "Compound 15h",
            "Rhabdomyosarcoma",
            "Protein structure",
            "Biological functions",
            "Structure-activity relationships",
            "G9a inhibitors",
            "Medicinal chemistry",
            "G9a inhibition",
            "Potential solutions",
            "Epigenetics",
            "DNA sequence",
            "Phenotype",
            "Histones",
            "EHMT2",
            "Euchromatin histone methyltransferase 2",
            "Su(var)3-9 family",
            "HKMTs",
            "Histone lysine methyltransferases",
            "SET domain",
            "Alternative splicing",
            "EHMT2-SP1",
            "Nonhistone proteins",
            "Methylation",
            "Epigenetic marks",
            "Cellular functions",
            "Meiosis",
            "Tissue differentiation",
            "Invasive metastasis",
            "Epithelial-mesenchymal transition",
            "EMT",
            "Hypoxic conditions",
            "DNA repair",
            "Corepressor complexes",
            "Signaling pathways",
            "Glucocorticoid receptor",
            "GR",
            "Gene expression",
            "Solid tumors",
            "Hematological malignancies",
            "Neurodegenerative disorders",
            "Fibrosis",
            "\u03b2-hemoglobinopathies",
            "Tumor stemness",
            "Invasive metastasis",
            "Recurrence",
            "Cellular resistance",
            "Cancer cells",
            "Biomarker",
            "UNC0638",
            "UNC0642",
            "G9a chemical probes",
            "G9a proteolysis-targeting chimera",
            "PROTAC",
            "G9D-4",
            "G9a-like protein",
            "GLP",
            "Cytotoxicity",
            "Pharmacokinetics",
            "Protein structure",
            "Biological functions",
            "Design strategies",
            "SARs",
            "Shortcomings",
            "Future development",
            "Activation domain",
            "AD",
            "Glu-rich region",
            "Nuclear localization signal",
            "NLS",
            "Cys-rich region",
            "Ankyrin repeat domain",
            "ANK",
            "Pre-SET",
            "Post-SET",
            "S-adenosylmethionine",
            "SAM",
            "S-adenosylhomocysteine",
            "SAH",
            "Protein-protein interactions",
            "PPIs",
            "H3K9me2",
            "H3K9me3",
            "Transcription factors",
            "TFs",
            "CDP/cut",
            "Gfi1",
            "PRDI-BF1",
            "NRSF",
            "UHRF1",
            "Noncoding RNA",
            "Homologous Suv39h",
            "Enhancer of zest homologue 2",
            "EZH2",
            "DNA methyltransferases",
            "DNMTs",
            "DNMT3a",
            "DNMT1",
            "E-calmodulin",
            "Prolyl hydroxylase domain",
            "PHD",
            "Asparaginyl hydroxylase factor inhibiting hypoxia inducible factor",
            "FIH",
            "LIG1",
            "CK2-G9a-RPA axis",
            "CARM1",
            "p300",
            "ITGB3",
            "Glycolysis",
            "Serine-glycine biosynthetic pathway",
            "Citric acid cycle",
            "Iron metabolism",
            "BPSD",
            "Behavioral and psychological symptoms of dementia",
            "Amyloid deposition",
            "Neuronal plasticity damage",
            "SAMP8 mice",
            "JNK pathway",
            "LC3B",
            "p62",
            "Autophagosome-like structures",
            "Glial maturation factor \u03b2",
            "GMFB",
            "Neurotrophic factors",
            "Bdnf",
            "NT3",
            "Ngf",
            "Amyloid \u03b2",
            "A\u03b2",
            "Late long-term potentiation",
            "LTP",
            "Synaptic tagging and capture",
            "STC",
            "IPF",
            "Idiopathic pulmonary fibrosis",
            "CXCL10",
            "hHSCs",
            "Human hepatic stellate cells",
            "Transforming growth factor-\u03b21",
            "TGF\u03b21",
            "Fetal hemoglobin",
            "HbF",
            "Adult hemoglobin 1",
            "HbA1",
            "\u1e9e-hemoglobinopathies",
            "LCR",
            "Gut immune homeostasis",
            "IL-17",
            "Foxp3+ Treg cells",
            "IBD",
            "Inflammatory bowel disease",
            "CAD",
            "Cardiovascular diseases",
            "ACD",
            "Autophagic cell death",
            "MMP",
            "IL6"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1090-1091.pdf": {
        "title": "A Systematic Blueprint to Ligand the Proteome",
        "keywords": [
            "Target 2035 initiative",
            "pharmacological tools",
            "human proteome",
            "DNA-encoded library",
            "machine learning",
            "ligandability",
            "WD40 repeat",
            "WD40 repeat target class",
            "potent ligand",
            "selective ligand",
            "small-molecule therapeutics",
            "high-throughput screen",
            "HTS",
            "chemical starting points",
            "medicinal chemistry optimization",
            "drug discovery",
            "target screening",
            "Journal of Medicinal Chemistry",
            "Ackloo et al.",
            "systematic workflow",
            "expression",
            "purification",
            "screening",
            "hit expansion",
            "WDR",
            "WDR class of proteins",
            "ligandability scores",
            "validated hits",
            "chemical starting points",
            "protein family",
            "Hit ID approaches",
            "compound libraries",
            "molecules",
            "drug discovery programs",
            "chemical space",
            "drug-like molecules",
            "DNA-encoded library",
            "DEL",
            "bespoke libraries",
            "combinatorial chemistry",
            "chemical diversity",
            "high-compression mixtures",
            "affinity enrichment",
            "DNA barcode",
            "binding information",
            "chemical resynthesis",
            "isolated compound stocks",
            "downstream applications",
            "computational approaches",
            "machine learning",
            "ML",
            "DEL-ML",
            "commercially accessible libraries",
            "gene-family analysis",
            "industrialized scale",
            "WDR domains",
            "disc-shaped folds",
            "beta-propeller motifs",
            "central channel",
            "physicochemical properties",
            "protein-protein interaction motifs",
            "ubiquitin proteasome system",
            "epigenetics",
            "splicing",
            "immune response",
            "recombinant expression",
            "DEL-ML pipeline",
            "primary data analysis",
            "commercially available hits",
            "orthogonal validation",
            "biophysical studies",
            "structural studies",
            "cellular engagement studies",
            "Tanimoto similarity scores",
            "ML expansion",
            "WDR5",
            "peptide tool",
            "central pocket",
            "selectivity",
            "high-resolution cocrystal structure",
            "structure-based design",
            "protein class",
            "generalized approach",
            "gene families",
            "Target 2035",
            "chemical probes",
            "biological probes",
            "human proteome",
            "Hit ID approaches",
            "binding",
            "function",
            "downstream assays",
            "small-molecule Hit ID",
            "ligandable proteome",
            "Discovery Sciences",
            "Pfizer Worldwide Research and Development",
            "Groton, Connecticut",
            "Matthew F. Calabrese",
            "J. Med. Chem.",
            "DOI",
            "Nat. Rev. Drug Discov",
            "J. Proteome Res.",
            "ACS Omega",
            "Drug Discov Today"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1092-1112.pdf": {
        "title": "A Target Class Ligandability Evaluation of WD40 Repeat-Containing Proteins",
        "keywords": [
            "WD40 repeat proteins",
            "WDR proteins",
            "Ligandability evaluation",
            "Target class",
            "Drug discovery",
            "Small molecule ligands",
            "Protein-protein interaction",
            "PPI",
            "DNA-encoded chemical library",
            "DEL",
            "Machine learning",
            "DEL-ML",
            "Virtual libraries",
            "Protein production",
            "Crystallography",
            "Biophysical assays",
            "Biochemical assays",
            "Cellular assays",
            "Hit-finding campaign",
            "Drug-like ligands",
            "Therapeutics",
            "Disease-relevant targets",
            "WDR domain",
            "Human genome",
            "Genetic links",
            "Cellular processes",
            "Epigenetics",
            "Ubiquitin signaling",
            "DNA repair",
            "RNA splicing",
            "Immune system signaling",
            "Essential genes",
            "Cancer",
            "Neurological diseases",
            "Inflammatory diseases",
            "GPCRs",
            "Kinases",
            "Substrate recognition",
            "Scaffolding subunit",
            "Multiprotein complexes",
            "Beta-propeller",
            "Central pocket",
            "Post-translational modifications",
            "Nucleic acids",
            "Drug-like small molecules",
            "Antagonists",
            "Mixed Lineage Leukemia",
            "MLL",
            "Histone methyltransferase",
            "Polycomb repression complex 2",
            "PRC2",
            "Degrader modalities",
            "DCAF1",
            "DDB1",
            "Cullin-RING ubiquitin ligase complex",
            "E3 ligase",
            "BTRC",
            "Beta-Catenin",
            "CDC20",
            "Target 2035",
            "High-throughput screening",
            "Off-DNA synthesis",
            "AlphaFold",
            "Electrostatics",
            "Drug-like density",
            "DLID",
            "Recombinant expression",
            "Purification",
            "Baculovirus Expression Vector System",
            "BEVS",
            "Sf9 cells",
            "Homology modeling",
            "SDS-PAGE",
            "Mass spectrometry",
            "Differential scanning fluorimetry",
            "DSF",
            "Size exclusion chromatography",
            "RMSD",
            "UTP15",
            "EIF2A",
            "PTEs",
            "Enamine REAL",
            "Mcule",
            "Solubility",
            "Aggregation",
            "Dynamic light scattering",
            "DLS",
            "Surface plasmon resonance",
            "SPR",
            "ECFP6 fingerprints",
            "Tanimoto distances",
            "X-ray crystallography",
            "Peptide displacement assay",
            "Fluorescence polarization",
            "FP",
            "Hydrogen-deuterium exchange mass spectrometry",
            "HDX-MS",
            "MR45279",
            "MR46654",
            "RAB7A",
            "MR43378",
            "MR44397",
            "OICR-9429",
            "NanoLuc Luciferase",
            "NL",
            "HiBiT Cellular Thermal Shift Assay",
            "HiBiT CETSA",
            "NanoBRET",
            "PROTACs",
            "Molecular glues",
            "CORO1A",
            "ACTB",
            "FBXW7",
            "Cyclin E1",
            "EED",
            "RBBP4",
            "WDR5",
            "WDR12",
            "WDR91",
            "LRRK2",
            "RFWD3",
            "ATG16L1",
            "DNMT3A",
            "SETDB1"
        ]
    },
    "gs://literature-resources-bucket/Journal of Medicinal Chemistry/2025 Volume 68/02  (0851-2043)/1113-1133.pdf": {
        "title": "Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders",
        "keywords": [
            "SMARCA2",
            "SMARCA4",
            "Bromodomain Ligands",
            "PROTAC Degraders",
            "High-Affinity",
            "Selective",
            "PROTAC",
            "Degraders",
            "SWI/SNF",
            "Chromatin Remodeling",
            "ATPase Subunits",
            "Synthetic-Lethal Relationship",
            "Therapeutic Strategy",
            "Human Cancers",
            "Inactivated Mutated SMARCA4",
            "Design",
            "Synthesis",
            "Biological Evaluation",
            "Novel Ligands",
            "VHL-1 Ligands",
            "Bromodomain Ligands",
            "Potent Degrader",
            "Selective Degrader",
            "PBRM1 Degrader",
            "Multisubunit Complex",
            "Transcriptional Regulation",
            "ATP-Dependent Helicases",
            "BRM",
            "Brahma Homologue",
            "BRG1",
            "Brahma-Related Gene 1",
            "Sequence Homology",
            "Human Diseases",
            "Human Tumor Sequencing",
            "Loss-of-Function Mutations",
            "Non-Small-Cell Lung Cancer",
            "Ovarian Cancer",
            "Melanoma",
            "SMARCA4 Inactivation",
            "Proliferation",
            "Survival",
            "Synthetic Lethal Target",
            "Normal Cells",
            "Wild-Type",
            "Functional Proteins",
            "Conserved Bromodomains",
            "ATPase Domains",
            "Small-Molecule Inhibitors",
            "Antiproliferative Activity",
            "Cancer Cells",
            "Mutant Protein",
            "ATPase Domain Inhibitors",
            "Tolerability",
            "Mice",
            "Dual Inhibition",
            "Toxicity Issue",
            "Clinical Trials",
            "Allosteric Inhibitor",
            "Identical Binding Pockets",
            "Targeted Protein Degradation",
            "TPD",
            "Catalytic Nature",
            "Exceptional Selectivity",
            "ACBI1",
            "A947",
            "ACBI2",
            "DC50 Values",
            "Maximum Degradation",
            "Dmax",
            "Mouse Tissues",
            "Structure-Activity Relationships",
            "SARs",
            "Cocrystal Structure",
            "Binding Affinities",
            "Spiro Rings",
            "Selectivity",
            "TR-FRET Assays",
            "Recombinant Human Proteins",
            "Hydrogen Bonds",
            "Hydrophobic Interactions",
            "Charge-Charge Interactions",
            "Piperidinyl Group",
            "Solvent Environment",
            "Cl-Phenyl Group",
            "VHL-1",
            "HiBiT Assays",
            "Methylene Unit",
            "Flexible Linkers",
            "Trans-4-Methylcyclohexane-1-Carboxylic Linker",
            "Western Blot Analysis",
            "Immunoblotting",
            "PBRM1 Protein",
            "Cell Growth Inhibition",
            "GI50 Values",
            "Triple Degrader",
            "Degrader-Antibody Conjugates",
            "DACs",
            "Suzuki Reaction",
            "Catalytic Hydrogenation",
            "SNAr Substitution",
            "SN1 Substitution",
            "DIPEA",
            "DMF",
            "HATU",
            "TFA",
            "DCM",
            "MeONa",
            "MeOH",
            "LiHMDS",
            "CS2CO3",
            "K2CO3",
            "H2O2",
            "Pd/C"
        ]
    }
}